The invention relates to the modulation of gene expression. In particular, the
invention relates to compositions comprising antisense oligonucleotides which inhibit
expression of a gene in operable association with protein effectors of a product
of that gene, and methods of using the same.
In addition, the invention relates to the modulation of mammalian gene expression
regulated by methylation.